Tempo Therapeutics, Inc. is a biotechnology start-up pioneering a fundamental shift in the way we develop regenerative tissue therapies by circumventing the natural fibrotic response and tissue inflammation that limit the body’s own regenerative capacity. Tempo’s biomaterial technology, the Microporous Annealed Particle (MAP) gel, is unique in enabling regenerative healing in damaged tissue without the delivery of stem cells or growth factors. Tempo is developing a suite of low cost easy-to-manufacture clinical solutions, from scarless skin healing to regenerative cardiac and spinal therapies that will sculpt the new field of cell-free regenerative medicine.
>$3B spent each year in the US
scar tissue leads to disease
>$10B in R&D efforts over 35 years
without stem cell delivery or growth factors